Vaishali Pharma Limited — Others, 11-02-2025: Copy of Newspaper Publication

Vaishali Pharma Limited has held a board meeting to approve the financial results for the quarter and half-year ending December 31, 2024. Total income from operations was reported at ₹90.39 crore, with a net profit of ₹3.29 crore after taxes. This positive performance marks a recovery from the previous year's loss of ₹8.01 crore for the same period.

This announcement may enhance investor sentiment as it reflects improved operational efficiency and recovery in profitability. The management's focus on generating income could indicate a strategic pivot towards strengthening the financial position, supporting a positive outlook for the company.